Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-25-024004

Director acquired 40,258 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BUCHI J KEVIN Director 2025-05-05 Option exercise +40,258 40,258 D
Derivatives
BUCHI J KEVIN Director 2025-05-05 Option exercise · Restricted Stock Units −40,258 0 D
BUCHI J KEVIN Director 2025-05-06 Grant or award · Restricted Stock Units +34,819 34,819 D
Loading xslF345X05/wk-form4_1746748442.xml…